Skip to content

Clinical trials

Lung Diseases trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: South Africa Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20081
20093
20102
20131
20142
20171
20181
20221
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting5
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Bayer3
Novartis Pharmaceuticals3
Pfizer3
Upstream Bio Inc.2
Johns Hopkins University1
Population Health Research Institute1
University of California, Los Angeles1
University of KwaZulu1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases19
Respiratory Tract Diseases11
Asthma7
Bronchial Diseases6
Lung Diseases, Obstructive5
Pulmonary Disease, Chronic Obstructive4
Infections3
Respiratory Tract Infections3
Bronchitis, Chronic2
COVID-192

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.